FABRX AI’s Post

Stop by Aprecia Booth 13 to talk to Michael Pistone and Stuart Armstrong about how our 3DP technology can help to solve your drug delivery and formulation challenges.

📘 Exciting Announcement! 🎉 I'm thrilled to share that our book "3D Printing in Pharmaceuticals" has been published by Wiley Publications! 🚀 🔍 Explore the groundbreaking innovations and applications of 3D printing in the pharmaceutical industry, from personalized medicine to dosage forms revolution. Whether you're a researcher, industry professional, or enthusiast, this book offers insights into the future of medicine. 🌟 Grab your copy today and dive into the forefront of pharmaceutical technology! Available now at Wiley and leading bookstores. #3DPrinting #Pharmaceuticals #Innovation #Healthcare #NewBook #WileyPublications

🔔𝐅𝐎𝐂𝐔𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐖𝐄𝐄𝐊🔔 🌱🏥 Reducing Medicine and Raw Material Waste : MB Therapeutics' Commitment Every year, significant amounts of perfectly usable medication are discarded. Waste in the pharmaceutical industry is multifaceted, involving both the dispensing of medications in fixed quantities and the waste of raw materials during development phases. At MB Therapeutics, we address this urgent issue by adopting sustainable manufacturing practices and revolutionizing medication dispensing. Don't feel guilty about cluttering up your cupboards with unused or out-of-date medicine! To learn more, 𝐜𝐡𝐞𝐜𝐤 𝐨𝐮𝐭 𝐨𝐮𝐫 𝐥𝐚𝐭𝐞𝐬𝐭 𝐚𝐫𝐭𝐢𝐜𝐥𝐞 : 👉 https://lnkd.in/eby24N38 (EN) 👉 https://lnkd.in/exTz4c8V (FR) BIC de Montpellier Stéphane Roulon Ian Soulairol Léna Lemierre Sarah Cauquil MB Therapeutics #PersonalizedMedecine #Innovation

💊We are pleased to welcome the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology 2024, which will take place from March 18 to 21 at the Austria Center Vienna. Nanotechnology is one of several important new tools for targeting active ingredients to problem areas in the body. mRNA vaccines and cancer therapeutics are prominent areas of application. The role that nanotechnology already plays and what other tools, such as 3D printing, can be used in the future to create even more effective medicines will be the focus of the PBP World Meeting 2024. Full article (German Version only): https://bit.ly/3vfk4XN #AustriaCenterVienna #ACV #PBP

𝐓𝐫𝐢𝐚𝐬𝐭𝐞𝐤 𝐚𝐧𝐝 𝐁𝐢𝐨𝐍𝐓𝐞𝐜𝐡 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐞 𝐭𝐨 𝐃𝐞𝐯𝐞𝐥𝐨𝐩 𝟑𝐃 𝐏𝐫𝐢𝐧𝐭𝐞𝐝 𝐎𝐫𝐚𝐥 𝐑𝐍𝐀 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 Triastek Inc. Triastek, Inc., a leader in 3D printing pharmaceuticals, has entered a research collaboration and platform technology license agreement with BioNTech SE BioNTech SE to develop RNA therapeutics for oral delivery. This collaboration aims to provide groundbreaking therapies in an easy-to-administer oral formulation. Triastek will leverage its expertise in innovative oral tablet designs, optimizing RNA therapeutic delivery across the gastrointestinal mucosa, minimizing degradation, and enhancing absorption. The unique external and internal tablet geometries, including multi-layer and multi-compartment designs, will be key to optimizing the delivery of these novel therapeutics. "We are honored to collaborate with BioNTech, a leader in transformative medicines," said Dr. Senping Cheng Senping Cheng, Founder and CEO of Triastek. "This partnership is a promising milestone in advancing oral RNA therapeutics using 3D printing technology." Triastek will receive an upfront payment of $10 million and is eligible for over $1.2 billion in milestone payments, plus tiered royalties on future product sales. #DrugDelivery #Therapeutics #RNAResearch #NextGenTherapeutics #PharmaPartnership #ClinicalResearch #PharmaCollaboration

Tod and Anders on how to minimizing batch change over time and improve production time on equipment in pharmaceutical production, how to implement and automate assisted line clearance. A topic we have experienced has a great interest - latest on ACHEMA in July.

Mix small batches with the need to take drugs to the market faster and more efficiently than ever and you get a cocktail that can disrupt a whole industry 🌪 And it means that pharma companies will have to rethink key processes to keep up. In other words: Pharmaceutical manufacturing is about to change 🚀 Watch the video to see Anders Meister and Pharma Industry Expert Tod Urquhart discuss some of the new technologies that will support this shift. **** If you want to know more, head over to our website to read more about technologies like automated line clearance and inline label printing. #pharma #pharmaceuticalmanufacturing #smartfactory #pharma40 #lineclearance #inlineprinting #reimaginepharma

𝟯𝗗 𝗽𝗿𝗶𝗻𝘁𝗲𝗱 𝘀𝗰𝗮𝗳𝗳𝗼𝗹𝗱𝘀 𝗮𝘀 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗱𝗲𝘃𝗶𝗰𝗲𝘀 𝗳𝗼𝗿 𝗻𝗮𝗻𝗼𝗰𝗿𝘆𝘀𝘁𝗮𝗹𝘀: 𝗔 𝗽𝗿𝗼𝗼𝗳 𝗼𝗳 𝗰𝗼𝗻𝗰𝗲𝗽𝘁 𝗹𝗼𝗮𝗱𝗶𝗻𝗴 𝗔𝘁𝗼𝗿𝘃𝗮𝘀𝘁𝗮𝘁𝗶𝗻 𝘄𝗶𝘁𝗵 𝗲𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝗽𝗿𝗼𝗽𝗲𝗿𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝘀𝘂𝗯𝗹𝗶𝗻𝗴𝘂𝗮𝗹 𝗿𝗼𝘂𝘁𝗲 𝗼𝗳 𝗮𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 by Bruno Barrientos, Daniel Andrés Real, Alan R., Franco Ambrosioni, Daniel Allemandi, Santiago Daniel Palma, Juan Pablo Real, Increasing the solubility of drugs is a recurrent objective of pharmaceutical research, and one of the most widespread strategies today is the formulation of nanocrystals (NCs). Beyond the many advantages of formulating NCs, their incorporation into solid dosage forms remains a challenge that limits their use. In this work, the researchers set out to load Atorvastatin NCs (ATV-NCs) in a delivery device by combining 3D scaffolds with an “in situ” loading method such as freeze-drying. When comparing two infill patterns for the scaffolds at two different percentages, the one with the highest NCs load was chosen (Gyroid 20 % infill pattern, 13.8 ± 0.5 mg). Colloidal stability studies of NCs suggest instability in acidic media, and therefore, the system is postulated for use as a sublingual device, potentially bypassing stomach and hepatic first-pass effects.  Read more in the article.

3D Printing: A new era for customized medicine? Read more about how this innovative technology promises to revolutionize drug manufacturing, improve patient outcomes and pave the way for a truly personalized, effective, and patient-centered healthcare future. 💊

The pharmaceutical engineering and manufacturing market is rapidly evolving with advancements in technology and innovation. Emerging trends such as CRISPR-Cas9, Next-Generation Sequencing (NGS), AI and Machine Learning, 3D Printing, and Nanotechnology are transforming drug development processes, improving efficiency, and reducing costs. As the industry embraces digital transformation, integrating smart manufacturing and data analytics is crucial for maintaining competitiveness and regulatory compliance. Discover how these cutting-edge technologies are transforming patient care and the future of medicine in our latest insights. Read more: https://lnkd.in/gzXcX5qu #PharmaInnovation #HealthcareTech #FutureOfMedicine #DrugDevelopment #PersonalizedMedicine #AIinPharma #DigitalHealth #marketresearch #marketingstrategy Harsh Shah Velox Consultants